NASDAQ: CRVL · Insurance Brokers
CorVel (CRVL) fair value: undervalued or overvalued?
As of 16 Nov 2026, Faircurve's model values CorVel (CRVL) at $84.82 a share. The stock last closed at $87.34, which puts the model's fair value 2.9% below the price. On the model's bands that reads as Fairly valued.
Revalued . Price is the close of 16 Nov 2026. CorVel Corporation.
The report adds the live price, the chart against the range the options market prices and the next earnings date. No account needed.
This week, in three parts
What happenedThe run of 16 Nov 2026 moved the fair value from $82.64 to $84.82 (+2.6%). The move is not broken down.
What the model makes of itThe price of $87.34 is 2.9% above it: Fairly valued, on a medium evidence grade.
What's nextNext report on 2 Feb 2027. Options prices imply a move of about 9% either way over the next month. The next weekly run is on Saturday 21 Nov 2026.
What price range does the model give CRVL?
The calibrated range for CRVL over 63 trading days is $79.11 to $96.91. It sits around the last close, and its width comes from the volatility that CRVL's own options imply (30% a year), calibrated weekly against realised prices (n = 8,038 past valuations, refreshed 14 Nov 2026). Ranges built this way held the price 60% of the time at this horizon. The fair value is the model's opinion and rides beside the range. It is not the centre of it.
The model's own simulated range, from the 20th to the 80th percentile of its runs, is $58.41 to $119.48. In 49% of the simulations the fair value came out above the price the model ran on.
Faircurve Insights · 16 Nov 2026
CorVel Corporation delivers comprehensive solutions that help employers, third-party administrators, insurance providers and government entities manage healthcare claims.
Faircurve's model gave CorVel a fair value of $84.82 a share on 16 Nov 2026, the midpoint of 2,000 simulations. The previous run, on 7 Nov 2026, gave $82.64, so the fair value moved +2.6%. The model does not break down the move. The calibrated range over 63 trading days is $77.62 to $95.08. Ranges built this way held the price 60% of the time at this horizon, based on 8,038 past valuations refreshed 14 Nov 2026. The model's evidence grade is Medium. It looks at input completeness, the number and agreement of comparable companies, and the width of outcomes. It does not say whether the fair value is right.
CorVel scores 80 out of 100 on the model's quality composite, scored against comparable companies. Three factors stand out. Profitability scores 100, with ROIC of 62.8% against a peer median of 13.0%. Balance sheet scores 100, with net debt to EBITDA of -1.27x against a peer median of 2.57x. Stability scores 99, with five-year EBITDA margin downside volatility of 0.8 points against a peer median of 9.7 points. The model compares CorVel with Ryan Specialty Holdings, Brown & Brown, Aon, Arthur J. Gallagher, Marsh & McLennan, Goosehead Insurance and Willis Towers Watson.
Written from the figures on this page for the 16 Nov 2026 valuation and checked by rule before publishing: every number is one printed here, no forecast, no instruction. The price, the gap and the verdict are the page's own and change daily. Not a recommendation.
The Global Pulse
Faircurve's note after each US session, in your inbox. No account needed.
When does CRVL report earnings, and how has the stock reacted?
CorVel's next earnings report is scheduled for 2 Feb 2027. Companies can move their dates.
Options prices on 16 Nov 2026 imply a move of about 10.7% in either direction through the nearest expiry, about 59 days out. That is the size the market is pricing, not a direction. CRVL's 30 day implied volatility works out to about 8.7% over one month.
Around its last 8 reports: what the options market priced, and what followed
Each move runs from the last close before the report to the first close after it, so it covers companies that report before the open and after the close. The median size across CRVL's last 8 reports, ignoring direction, was 5.3%.
How does CRVL score on business quality?
CorVel's overall quality score is 80 out of 100. Each factor below is a score against comparable companies, not a percentile of the metric beside it.
| Factor | Score (0 to 100) | Headline measure | Peer median |
|---|---|---|---|
| ProfitabilityReturn on invested capital against the peer group, with a bonus for an improving trend. | 100 | 62.8%ROIC | 13.0% |
| Earnings qualityHow much of reported profit is cash: free cash flow to net income, and the accrual ratio (the share of earnings that is not cash). | 72 | 1.05xFCF / net income | 1.26x |
| Growth qualityTrailing revenue growth, forward growth from consensus, and the direction of analysts' rating changes. | 50 | 7.0%Revenue growth, trailing | 8.3% |
| Capital disciplineReinvestment efficiency (capital spending per unit of revenue) and net buybacks. | 58 | 1.7%Net buybacks / market value | 2.6% |
| Balance sheetNet debt to EBITDA and interest coverage. | 100 | -1.27xNet debt / EBITDA | 2.57x |
| StabilityDownside volatility of the EBITDA margin over the last five years. | 99 | 0.8 ptsEBITDA margin downside volatility, 5y | 9.7 pts |
How does CRVL compare with similar companies?
The companies in insurance brokers closest to CorVel in market value, each on the same model and the same date.
| Company | Last close | Model fair value | Gap | Model verdict |
|---|---|---|---|---|
| RYAN Ryan Specialty Holdings, Inc. | $47.86 | $59.13 | +23.5% | Undervalued |
| GSHD Goosehead Insurance, Inc | $48.81 | $45.85 | -6.1% | Low evidence grade |
| BRO Brown & Brown, Inc. | $73.51 | $76.77 | +4.4% | Fairly valued |
| WTW Willis Towers Watson Public Limited Company | $338.13 | $368.44 | +9.0% | Low evidence grade |
| AON Aon plc | $343.12 | $329.38 | -4.0% | Fairly valued |
| AJG Arthur J. Gallagher & Co. | $287.00 | $286.93 | 0.0% | Fairly valued |
| MRSH Marsh & McLennan Companies, Inc. | $209.88 | $208.13 | -0.8% | Fairly valued |
What the comparable companies' multiples alone would give for CRVL, the peer-implied price, is $46.88 a share on this run. The fair value weighs that against the company's own multiple.
CorVel at a glance
CorVel Corporation delivers comprehensive solutions designed to assist employers, third-party administrators, insurance providers, and government entities in effectively managing healthcare claims.
- Market value
- $4.3B
- Sector
- Financial Services
- Industry
- Insurance Brokers
- Beta to the US market
- 0.01
- First valued by Faircurve
- 11 Jul 2026
At the close of 16 Nov 2026, 56.8% of the 1,085 graded US stocks the model covers traded below the model's fair value. CRVL was not among them.
How the fair value is worked out: the model prices CorVel on the value of the whole business against its operating profit, compared with where that ratio has sat before (EV/EBITDA against its own history), runs 2,000 simulations across its inputs and takes the midpoint. The full method is documented here.
What changed in the latest valuation?
On 7 Nov 2026 the model's fair value for CRVL was $82.64. As of 16 Nov 2026 it is $84.82, a change of +2.6%. The move is not broken down. The model revalues every stock it covers each week, and again after an earnings report.
Questions about CorVel's valuation
Is CorVel stock undervalued or overvalued?
On Faircurve's model, CRVL reads as Fairly valued as of 16 Nov 2026. The model's fair value is $84.82 a share against a last close of $87.34, a gap of -2.9%.
What is CRVL's fair value?
$84.82 a share as of 16 Nov 2026, the midpoint of 2,000 simulations. The model's own 20th to 80th percentile range is $58.41 to $119.48.
What price range does the model give CRVL?
$79.11 to $96.91 over 63 trading days. Ranges built this way held the price 60% of the time across 8,038 past valuations, refreshed 14 Nov 2026.
When does CorVel report earnings next?
The next report is scheduled for 2 Feb 2027. Companies can move their dates.
How much has CRVL moved on past earnings reports?
Across its last 8 reports the median two session move was 5.3%, ignoring direction. The largest was -29.6% around the report of 3 Feb 2026.
How confident is the model in this valuation?
The model's evidence grade for CRVL is medium. The grade looks at how complete the inputs are, how many comparable companies there are and how closely they agree, and how wide the range of outcomes is. It is not a probability that the fair value is right, or that the price reaches it.
The model's own ideas on CRVL
The model holds no idea open on CRVL today. Signed-in readers see the rule each idea runs on, the floor and the exit level the model set and its time limit, and the model's closed ideas on CRVL with their outcomes. A free account is enough.